S&P・Nasdaq 本質的価値 お問い合わせ

Repligen Corporation RGEN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
61/100
1/7 Pass
SharesGrow Intrinsic Value
$186.82
+42.6%
Analyst Price Target
$183.00
+39.7%

Repligen Corporation (RGEN) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は EDDLEMAN ROY T 370,000 株保有. その他の主要保有者には HERLIHY WALTER C および DAWES KAREN A.

過去12ヶ月間にインサイダーは 41 件の取引を実施 RGEN 株式 — 17 件の買い (評価額 $9.83M) および 6 件の売り (評価額 $1.91M). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.

RGEN インサイダー保有状況

最大保有者
EDDLEMAN ROY T
370,000 株
買い(12ヶ月)
17
$9.83M 評価額
売り(12ヶ月)
6
$1.91M 評価額
12ヶ月取引活動
買い 41%
売り 15%
インサイダー上位保有者
# 氏名 役職 保有株数 最終申告日 相対規模
1 Eddleman Roy T 10 Percent Owner 370,000 2018-08-13
100%
2 Herlihy Walter C President, CEO 262,430 2015-05-14
71%
3 Dawes Karen A Director 91,821 2025-12-18
25%
4 Hunt Anthony Director 89,062 2026-03-03
24%
5 Snodgres Jon Chief Financial Officer 37,381 2023-05-16
10%
6 Cooper Glenn L Md Director 35,709 2019-05-28
10%
7 Gebski Christine See Remarks 27,419 2024-05-15
7%
8 Loeillot Olivier Chief Executive Officer 25,890 2026-03-23
7%
9 Ryan Thomas F Jr Director 12,337 2021-11-04
3%
10 Rusche James R Senior Vice President 9,895 2016-03-01
3%
11 Douglass Brian Robb Chief Product Officer 8,319 2026-03-03
2%
12 Garland Jason K CFO 8,315 2026-03-23
2%
13 Bylund James Chief Operating Officer 8,315 2026-03-23
2%
14 Benjamin Howard VP Business Development 8,289 2017-05-22
2%
15 Kuriyel Ralf Senior VP, R&d 5,669 2026-03-23
2%
16 Hughes Violetta Chief Accounting Officer 3,914 2025-09-04
1%
17 Muir Glenn P Director 3,366 2025-12-17
1%
18 Goldberg Alfred Lewis Director 1,992 2015-05-26
1%
19 Konstantinov Konstantin Director 1,800 2025-05-19
0%
20 Mhatre Rohin Director 1,800 2025-05-19
0%
最近の取引 (過去12ヶ月)
日付 氏名 役職 種類 株数 株価 価値
2026-03-05 Loeillot Olivier Chief Executive Officer RSU 付与(制限付株式) 25,890 $141.91 $3.67M
2026-03-05 Bylund James Chief Operating Officer RSU 付与(制限付株式) 8,315 $141.91 $1.18M
2026-03-05 Garland Jason K CFO RSU 付与(制限付株式) 8,315 $141.91 $1.18M
2026-03-05 Kuriyel Ralf Senior VP, R&d RSU 付与(制限付株式) 5,669 $141.91 $804.49K
2026-03-04 Bylund James Chief Operating Officer RSU 源泉徴収 62 $125.84 $7.8K
2026-03-04 Kuriyel Ralf Senior VP, R&d RSU 源泉徴収 42 $125.84 $5.29K
2026-03-02 Douglass Brian Robb Chief Product Officer RSU 源泉徴収 221 $124.97 $27.62K
2026-03-02 Loeillot Olivier Chief Executive Officer RSU 源泉徴収 1,610 $124.97 $201.2K
2026-02-27 Loeillot Olivier Chief Executive Officer RSU 源泉徴収 344 $128.73 $44.28K
2026-03-02 Bylund James Chief Operating Officer RSU 源泉徴収 2,433 $124.97 $304.05K
2026-02-27 Bylund James Chief Operating Officer RSU 源泉徴収 1,478 $128.73 $190.26K
2026-03-02 Garland Jason K CFO RSU 源泉徴収 715 $124.97 $89.35K
2026-02-27 Garland Jason K CFO RSU 源泉徴収 327 $128.73 $42.09K
2026-03-02 Kuriyel Ralf Senior VP, R&d RSU 源泉徴収 923 $124.97 $115.35K
2026-02-27 Kuriyel Ralf Senior VP, R&d RSU 源泉徴収 444 $128.73 $57.16K
2026-03-02 Hunt Anthony Director RSU 源泉徴収 9,897 $124.97 $1.24M
2025-12-31 Douglass Brian Robb Chief Product Officer RSU 付与(制限付株式) 2,143 $163.86 $351.15K
2025-12-31 Douglass Brian Robb Chief Product Officer 不明 7,020 $167.72 $1.18M
2025-12-17 Dawes Karen A Director 情報に基づく売り 275 $161.00 $44.28K
2025-12-16 Muir Glenn P Director オプション行使 3,366 $26.12 $87.92K
2025-12-04 Hunt Anthony Director その他(売り) 2,000 - -
2025-11-25 Loeillot Olivier Chief Executive Officer 情報に基づく売り 7,041 $170.00 $1.2M
2025-11-18 Bylund James Chief Operating Officer 情報に基づく売り 2,191 $151.21 $331.3K
2025-11-13 Hunt Anthony Director オプション行使 2,952 $33.87 $99.98K
2025-11-12 Hunt Anthony Director 情報に基づく売り 464 $158.51 $73.55K
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る